These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 8841510

  • 1. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
    Bhattacharya S, Ghosh M, Sadhu U, Dutta S, Sanyal U.
    Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the anticancer property of a new alpha-methylene-gamma-lactone derivative of phthalimide.
    Sanyal U, Dutta S, Das H.
    Neoplasma; 1995; 42(3):129-32. PubMed ID: 7637822
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of phthalmustine, a new anticancer compound. I. Effect on Dalton's ascitic lymphoma in mice.
    Bhattacharya S, Ganguly C, Sanyal U, Das S.
    Neoplasma; 1994; 41(1):35-8. PubMed ID: 8202193
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent.
    Samanta S, Pain A, Dutta S, Sanyal U.
    J Exp Clin Cancer Res; 2002 Mar; 21(1):87-93. PubMed ID: 12071535
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
    Pain A, Samanta S, Dutta S, Saxena AK, Shanmugavel M, Kampasi H, Qazi GN, Sanyal U.
    J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.
    Samanta S, Pain A, Ghosh M, Dutta S, Sanyal U.
    Exp Oncol; 2005 Dec; 27(4):279-85. PubMed ID: 16404347
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity of Hygrophila spinosa on Ehrlich ascites carcinoma and sarcoma-180 induced mice.
    Mazumdar UK, Gupta M, Maiti S, Mukherjee D.
    Indian J Exp Biol; 1997 May; 35(5):473-7. PubMed ID: 9378516
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of anticancer activity of Cleome gynandra on Ehrlich's Ascites Carcinoma treated mice.
    Bala A, Kar B, Haldar PK, Mazumder UK, Bera S.
    J Ethnopharmacol; 2010 May 04; 129(1):131-4. PubMed ID: 20307641
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and evaluation of ethylnitrosoureas of substituted naphthalimides as anticancer compounds.
    Pain A, Samanta S, Dutta S, Saxena AK, Shanmugavel M, Sharma M, Qazi GN, Sanyal U.
    Acta Pol Pharm; 2007 May 04; 64(1):27-33. PubMed ID: 17665847
    [Abstract] [Full Text] [Related]

  • 10. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R, Jungstand W, Gutsche W, Grimm H, Fritsch S.
    Acta Biol Med Ger; 1967 May 04; 19(4):543-58. PubMed ID: 5596676
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of 'cypenhymustine', a new anticancer compound, in murine tumour models.
    Sanyal U, Bhattacharya S, Sadhu U, Dutta S, Das H, Ghosh M.
    Cancer Lett; 1993 Jun 15; 70(1-2):1-6. PubMed ID: 8330289
    [Abstract] [Full Text] [Related]

  • 12. [On the growth-inhibiting effect of some new N mustard compounds on Ehrlich ascites carcinoma, Nemeth-Kellner lymphoma (ascites form) and solid sarcoma 180].
    Jugstand W, Gutsche W, Wiangke H.
    Arzneimittelforschung; 1966 May 15; 16(5):634-7. PubMed ID: 6014431
    [No Abstract] [Full Text] [Related]

  • 13. Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate.
    Chakraborty P, Sk UH, Bhattacharya S.
    Cancer Chemother Pharmacol; 2009 Oct 15; 64(5):971-80. PubMed ID: 19221751
    [Abstract] [Full Text] [Related]

  • 14. [Cytostatic effect of vinylogous nitrogen mustard carbonamidium salts against transplanted tumors in an automatic preliminary test and a sequential test program].
    Gutsche W, Jungstand W, Wohlrabe K, Fischer GW, Lohs K.
    Arch Geschwulstforsch; 1972 Oct 15; 39(2):121-7. PubMed ID: 5065117
    [No Abstract] [Full Text] [Related]

  • 15. Antitumor metallocenes: new developments and toxicologic features.
    Köpf-Maier P, Köpf H.
    Anticancer Res; 1986 Oct 15; 6(2):227-33. PubMed ID: 3707060
    [Abstract] [Full Text] [Related]

  • 16. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
    Sur P, Bag SP, Sur B, Khanam JA.
    Neoplasma; 1997 Oct 15; 44(3):197-201. PubMed ID: 9372863
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
    Pain A, Samanta S, Dutta S, Saxena AK, Shanmugavel M, Kampasi H, Quazi GN, Sanyal U.
    Acta Pol Pharm; 2003 Oct 15; 60(4):285-91. PubMed ID: 14714857
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity and antioxidant role of Bauhinia racemosa against Ehrlich ascites carcinoma in Swiss albino mice [corrected].
    Gupta M, Mazumder UK, Kumar RS, Kumar TS.
    Acta Pharmacol Sin; 2004 Aug 15; 25(8):1070-6. PubMed ID: 15301742
    [Abstract] [Full Text] [Related]

  • 19. Some new aryl-sydnones: effects on murine tumours.
    Grynberg N, Gomes R, Shinzato T, Echevarria A, Miller J.
    Anticancer Res; 1992 Aug 15; 12(3):1025-8. PubMed ID: 1320354
    [Abstract] [Full Text] [Related]

  • 20. Carcinostatic effect of aliphatic aldehydes and aldehyde dehydrogenase activity in Ehrlich carcinoma, Sarcoma 180, and Yoshida AH 130 hepatoma.
    Perin A, Sessa A, Ciaranfi E.
    Cancer Res; 1978 Jul 15; 38(7):2180-4. PubMed ID: 207425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.